| Literature DB >> 31072074 |
Diogo Matias1,2, Marisa Nicolai3, Ana Sofia Fernandes4, Nuno Saraiva5, Joana Almeida6, Lucília Saraiva7, Célia Faustino8, Ana María Díaz-Lanza9, Catarina P Reis10,11, Patrícia Rijo12,13.
Abstract
Medicinal plants of the Plectranthus genus (Lamiaceae) are known for their ethnopharmacological relevance, mainly against infectious, dermatologic and gastrointestinal pathologies. Three Plectranthus species originated from South Africa, namely P. madagascariensis, P. neochilus and the rare P. porcatus were hereby screened for their antimicrobial and cytotoxic activities related with their known and/or potential ethnomedicinal uses. Twenty-six extracts were prepared by the combination of extraction methods (infusion, decoction, microwave-assisted, ultrasound-assisted, maceration and supercritical fluid extraction) with different polarity solvents (water, methanol, acetone and supercritical CO2). The comparison study of these extracts was elucidated through the corresponding chemical characterization and cytotoxic activity data. Therefore, the acetone extract from P. madagascariensis prepared by ultrasound extraction method revealed potent antibacterial activity against Gram-positive bacteria (1.95 < minimum inhibitory concentration (MIC) < 7.81 μg/mL), including a methicillin-resistant Staphylococcus aureus (MRSA) strain. Additionally, acetone extracts from both P. madagascariensis and P. neochilus exhibited relevant antibacterial activity against Gram-negative Klebsiella pneumonia (0.48 < MIC < 3.91 μg/mL), validating the traditional uses of such plants as anti-infectious agents. All methanolic extracts showed potent antioxidant effects at 100 μg/mL measured as their radical scavenging activity (60.8-89.0%) in the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. The P. madagascariensis extract obtained by maceration in acetone showed moderate cytotoxic effects in the MDA-MB-231 cell line (triple negative human breast carcinoma). The extract concentration that caused a 50% inhibition in cell viability (IC50) was 64.52 μg/mL. All extracts in this comparative study were profiled by high-performance liquid chromatography-HPLC with a diode-array detector-DAD (HPLC-DAD) and the main known bioactive components were identified in each extract, which included polyphenols (caffeic 1, chlorogenic 2 and rosmarinic 3 acids), abietane diterpenes (7α-acetoxy-6β-hydroxyroyleanone 4 and coleon U 5) and flavone glycosides (rutin 6 and naringin 7).Entities:
Keywords: Lamiaceae; Plectranthus; antimicrobial; cytotoxicity; diterpenes
Mesh:
Substances:
Year: 2019 PMID: 31072074 PMCID: PMC6571840 DOI: 10.3390/biom9050179
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Structures of caffeic 1, chlorogenic 2 and rosmarinic 3 acids, abietane diterpenes (7α-acetoxy-6β-hydroxyroyleanone 4 and coleon U 5) and flavone glycosides (rutin 6 and naringin 7).
Plectranthus spp. extraction yields according to solvent and extraction method, and radical scavenging activity (RSA) of the extracts (100 μg/mL) in the DPPH assay.
| Plant | Solvent | Extraction Method a | Dry Residue (g) | Yield (mg/g) | Extract | RSA b (%) |
|---|---|---|---|---|---|---|
|
| Water | INF | 0.23 ± 0.10 | 2.3 | E1 | <50 |
| MW | 0.11 ± 0.04 | 1.1 | E2 | <50 | ||
| DEC | 0.22 ± 0.02 | 2.2 | E3 | <50 | ||
|
| US | 0.151 | 1.5 | E4 | <50 | |
|
| 0.377 |
| E5 | <50 | ||
|
|
| 0.656 |
|
|
| |
|
| 1.146 |
|
|
| ||
| scCO2 | SCFE | 0.394 | 0.01 | E8 | <50 | |
| Acetone | R-SCFE | 0.885 | 0.03 | E9 | <50 | |
|
| Water | INF | 0.26 ± 0.04 | 2.6 | E10 | <50 |
| MW | 0.15 ± 0.04 | 1.5 | E11 | <50 | ||
| DEC | 0.22 ± 0.01 | 2.2 | E12 | <50 | ||
| Acetone | US | 0.180 | 1.8 | E13 | <50 | |
| MA | 0.125 | 1.3 | E14 | <50 | ||
|
|
| 0.702 |
|
|
| |
|
| 0.600 |
|
|
| ||
| scCO2 | SCFE | 0.251 | 0.8 | E17 | <50 | |
| Acetone | R-SCFE | 0.417 | 1.4 | E18 | <50 | |
|
| Water | INF | n/d | n/d | E19 | <50 |
| MW | n/d | n/d | E20 | <50 | ||
| Acetone | US | 0.865 | 8.7 | E21 | <50 | |
| MA | 0.872 | 8.7 | E22 | <50 | ||
|
|
| 1.566 |
|
|
| |
|
| 2.237 |
|
|
| ||
| scCO2 | SCFE | 0.191 | 0.64 | E25 | <50 | |
| Acetone | R-SCFE | 0.868 | 2.9 | E26 | <50 |
a DEC, decoction; INF, infusion; MA, maceration; MW, microwave-assisted extraction; SCFE, supercritical fluid extraction; R-SCFE, re-extraction of the SCFE remaining plant material; US, ultrasound-assisted extraction; n/d, not determined. b Positive control (ascorbic acid): 93.4%. In bold the most relevant results. DPPH: 2,2-diphenyl-1-picrylhydrazyl.
Diameter (mm) of microbial growth inhibition by bioactive extracts (10 mg/mL) in the well diffusion assay.
| Microbial Strains | Extract | Positive Control a | |||||||
|---|---|---|---|---|---|---|---|---|---|
| E4 | E5 | E6 | E7 | E13 | E14 | E15 | E16 | ||
|
| |||||||||
|
|
| 12 | 11 | 15 | 14 | 11 | 10 | 31 (VAN) | |
|
|
| 7 | 8 | 8 | 8 | 8 | 8 | 24 (VAN) | |
| 10 |
| nt | 13 | 15 | 11 | nt | 5 | 20 (VAN) | |
|
|
| 23 | 17 | 20 | 15 | 15 | 20 | 33 (RIF) | |
|
| |||||||||
|
|
| 5 | 5 | 5 | 5 | 5 | 5 | 25 (NOR) | |
a VAN, vancomycin (Gram-positive); RIF, rifampicin (mycobacteria) or NOR, norfloxacin (Gram-negative); well diameter, 5 mm; nt, not tested. In bold the most relevant results.
Minimum inhibitory concentration (MIC) values (μg/mL) for the most active Plectranthus spp. extracts.
| Microbial Strains | Extract | Positive Control a | ||
|---|---|---|---|---|
| E4 | E5 | E13 | ||
|
| ||||
|
| 62.5 | 125 | <0.48 (VAN) | |
|
| 250 | 250 | 7.81 (VAN) | |
|
| 15.62 | 31.25 | <0.98 (VAN) | |
|
| 62.5 | 62.5 | 7.81 (VAN) | |
| 31.25 | 62.5 | 15.62 | <0.48 (RIF) | |
|
| ||||
|
|
|
| 15.62 (NOR) | |
a Vancomycin (Gram-positive), rifampicin (mycobacteria) or norfloxacin (Gram-negative); well diameter, 5 mm. In bold the most relevant results.
Figure 2(A) The viability of MDA-MB-231 cells exposed to Plectranthus spp. extracts (15 μg/mL) for 48 h assessed by the crystal violet staining assay using doxorubicin (DOX, 5 μM) as positive control; (B) Concentration-response profile for the P. madagascariensis extract obtained by maceration in acetone. Results are expressed as mean ± standard deviation (SD) from at least two independent experiments. IC50: extract concentration producing 50% inhibition of cell viability.
Figure 3High-performance liquid chromatography (HPLC) fingerprinting (5–20 min section) of Plectranthus spp. extracts (10 mg/mL) obtained at 270 nm, chemical structures of their predominant constituents and correspondent retention times (Rt, min). Abs: absorbance.
Compounds detection in each Plectranthus spp. extract and their corresponding characteristic retention times.
| Extract | RT (min) | ||||||
|---|---|---|---|---|---|---|---|
| Clo 6.54 | Caf 8.32 | Nar 10.14 | Rut 11.67 | Ros 12.43 | Roy 14.75 | ColU15.44 | |
| E1 | + | + | − | + | + | − | − |
| E2 | + | + | − | + | + | − | − |
| E3 | + | + | − | + | + | − | − |
| E4 | + | + | − | + | + | + | − |
| E5 | + | + | − | − | + | + | + |
| E6 | + | + | − | − | + | − | − |
| E7 | + | + | − | − | + | − | − |
| E8 | + | + | − | − | + | + | − |
| E9 | + | + | − | + | + | + | − |
| E10 | + | + | − | + | + | − | − |
| E11 | + | + | − | + | + | − | − |
| E12 | + | + | − | + | + | − | − |
| E13 | + | + | − | + | + | − | − |
| E14 | + | + | − | − | + | − | − |
| E15 | + | + | − | + | + | − | − |
| E16 | + | + | − | − | + | − | − |
| E17 | + | − | − | − | − | − | − |
| E18 | + | + | − | − | + | − | − |
| E19 | − | + | + | + | + | − | − |
| E20 | + | + | + | + | + | − | − |
| E21 | − | + | + | − | − | − | − |
| E22 | + | + | + | − | + | − | − |
| E23 | − | − | − | − | − | − | − |
| E24 | − | + | + | − | − | − | − |
| E25 | + | − | − | − | − | − | − |
| E26 | + | + | + | − | + | − | − |
RT, characteristic retention time in the developed HPLC method; Clo, Chlorogenic acid 2; Caf, Cafeic acid 1; Nar, Naringin 7; Rut, Rutin 6; Ros, Rosmarinic acid 3; Roy, 7α-acetoxy-6β-hydroxyrooyleanone 4; ColU, Coleon U 5. + detected compound; − not detected.